 Therapeutic implications lipid-lowering agents progression renal disease Progressive deterioration renal function absence original cause injury past decade intense investigations factors responsible progressive nephron destruction hemodynamic stresses metabolic coagulation abnormalities glomerular injury Hyperlipidemia common abnormality renal disease protein-uria therapy lipid-lowering agents clofibric acid lovastatin lipids cholesterol proteinuria glomerular damage normotensive hypertensive models progressive renal disease beneficial effects changes systemic blood pressure glomerular injury notion cholesterol accompanying changes central lipid modulation glomerulosclerosis Clinically lipid abnormalities common patients renal disease atherosclerotic cardiovascular disease frequent cause death patients role lipids atherosclerotic disease similar effect lipids occurs microvasculature kidney unknown Whether therapeutic approaches hyperlipidemia patients renal disease measure renal protection experimental models renal disease unknown